204 related articles for article (PubMed ID: 31915073)
1. Oral submucous fibrosis: a contemporary narrative review with a proposed inter-professional approach for an early diagnosis and clinical management.
Rao NR; Villa A; More CB; Jayasinghe RD; Kerr AR; Johnson NW
J Otolaryngol Head Neck Surg; 2020 Jan; 49(1):3. PubMed ID: 31915073
[TBL] [Abstract][Full Text] [Related]
2. Guideline for the Diagnosis and Clinical Management of Oral Submucous Fibrosis.
;
Chin J Dent Res; 2023 Dec; 26(4):271-285. PubMed ID: 38126373
[TBL] [Abstract][Full Text] [Related]
3. Oral Submucous Fibrosis Secondary to Iron Deficiency Anemia: A Case Report, Etiopathogenesis and Management.
Bhattacharya PT; Khaitan T; Sarkar SB; Sinha R
J Nutr Health Aging; 2016 Feb; 20(2):205-8. PubMed ID: 26812518
[TBL] [Abstract][Full Text] [Related]
4. Oral submucous fibrosis in children: an alarming condition and challenges in management.
Rai A; Jain A; Arora A; Motiwale T
BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33758041
[TBL] [Abstract][Full Text] [Related]
5. Role of hemoglobin and serum iron in oral submucous fibrosis: a clinical study.
Karthik H; Nair P; Gharote HP; Agarwal K; Ramamurthy Bhat G; Kalyanpur Rajaram D
ScientificWorldJournal; 2012; 2012():254013. PubMed ID: 22654577
[TBL] [Abstract][Full Text] [Related]
6. Plasma fibrinogen degradation products in oral submucous fibrosis.
Gupta S; Jawanda MK; Mehta N; Arora V; Yadav V
J Int Soc Prev Community Dent; 2015; 5(3):141-6. PubMed ID: 26236671
[TBL] [Abstract][Full Text] [Related]
7. Oral submucous fibrosis: Newer proposed classification with critical updates in pathogenesis and management strategies.
Passi D; Bhanot P; Kacker D; Chahal D; Atri M; Panwar Y
Natl J Maxillofac Surg; 2017; 8(2):89-94. PubMed ID: 29386809
[TBL] [Abstract][Full Text] [Related]
8. Role of Antioxidant Vitamins in Oral Submucous Fibrosis: A Narrative Review.
Sune RV; Bhowate RR; Lohe VK; Dangore-Khasbage SB
Cureus; 2024 May; 16(5):e59596. PubMed ID: 38832153
[TBL] [Abstract][Full Text] [Related]
9. Oral submucous fibrosis: a guide to diagnosis and management.
Kotecha A
Br Dent J; 2024 Apr; 236(8):598. PubMed ID: 38671109
[No Abstract] [Full Text] [Related]
10. Oral Submucous Fibrosis and Scleroderma: A Review of the Etiopathogenesis, Clinicopathological Correlation, and Management Aspects.
J S; S L; Nair MV; R KT; Ramani P
Cureus; 2023 Aug; 15(8):e44502. PubMed ID: 37791189
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells in the management of oral submucous fibrosis-An enigma to be solved.
Kizhakkoottu S; Ramani P; Tilakaratne WM
J Oral Pathol Med; 2024 May; 53(5):275-276. PubMed ID: 38685571
[No Abstract] [Full Text] [Related]
12. Oral Submucous Fibrosis: A Review on Biomarkers, Pathogenic Mechanisms, and Treatments.
Shen YW; Shih YH; Fuh LJ; Shieh TM
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33008091
[TBL] [Abstract][Full Text] [Related]
13. Medicinal management of oral submucous fibrosis in the past decade- A systematic review.
More CB; Jatti Patil D; Rao NR
J Oral Biol Craniofac Res; 2020; 10(4):552-568. PubMed ID: 32939334
[TBL] [Abstract][Full Text] [Related]
14. Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer.
Warnakulasuriya S; Kujan O; Aguirre-Urizar JM; Bagan JV; González-Moles MÁ; Kerr AR; Lodi G; Mello FW; Monteiro L; Ogden GR; Sloan P; Johnson NW
Oral Dis; 2021 Nov; 27(8):1862-1880. PubMed ID: 33128420
[TBL] [Abstract][Full Text] [Related]
15. Genetic Susceptibility and Protein Expression of Extracellular Matrix Turnover-Related Genes in Oral Submucous Fibrosis.
Cheng RH; Wang YP; Chang JY; Pan YH; Chang MC; Jeng JH
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143101
[TBL] [Abstract][Full Text] [Related]
16. Research Achievements of Oral Submucous Fibrosis: Progress and Prospect.
Xu H; Lyu FY; Song JY; Xu YM; Jiang EH; Shang ZJ; Chen LL; Xu Z
Biomed Res Int; 2021; 2021():6631856. PubMed ID: 33791368
[TBL] [Abstract][Full Text] [Related]
17. A systematic review on the mechanisms of malignant transformation of oral submucous fibrosis.
Phulari RGS; Dave EJ
Eur J Cancer Prev; 2020 Sep; 29(5):470-473. PubMed ID: 32740174
[TBL] [Abstract][Full Text] [Related]
18. Herbal derivatives in the management of mouth opening in oral submucous fibrosis-A network meta-analysis.
Rajesh Kashyap R; Shanker Kashyap R
Oral Dis; 2021 Oct; 27(7):1606-1615. PubMed ID: 32671872
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
